Takeda Pharmaceutical Cash from Investing (TTM) Insights

Takeda Pharmaceutical Co Ltd (TAK)

13.37 +0.31 (+2.37%) USD | NYSE | May 09, 16:00

13.28 -0.09 (-0.67%) Pre-Market: 08:54

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2010. Upgrade now.

Date	Value
December 31, 2023	-6.025B
September 30, 2023	-5.878B
June 30, 2023	-5.707B
March 31, 2023	-4.496B
December 31, 2022	-1.443B
September 30, 2022	-1.708B
June 30, 2022	-1.852B
March 31, 2022	-1.765B
December 31, 2021	1.236B
September 30, 2021	2.507B
June 30, 2021	3.063B
March 31, 2021	3.712B
December 31, 2020	1.294B
September 30, 2020	-126.82M
June 30, 2020	3.072B
March 31, 2020	2.688B
December 31, 2019	-8.909B
September 30, 2019	-22.48B
June 30, 2019	-25.80B
March 31, 2019	-25.58B
December 31, 2018	-15.28B
September 30, 2018	-1.071B
June 30, 2018	-1.893B
March 31, 2018	-842.45M
December 31, 2017	-5.571B

Date	Value
September 30, 2017	-5.746B
June 30, 2017	-5.117B
March 31, 2017	-6.063B
December 31, 2016	-143.07M
September 30, 2016	-366.59M
June 30, 2016	-477.58M
March 31, 2016	-593.40M
December 31, 2015	-886.37M
September 30, 2015	255.31M
June 30, 2015	378.73M
March 31, 2015	835.33M
December 31, 2014	793.48M
September 30, 2014	-1.146B
June 30, 2014	-1.086B
March 31, 2014	-1.538B
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012
December 31, 2011
September 30, 2011

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-25.80B

Minimum

Jun 2019

3.712B

Maximum

Mar 2021

-3.611B

Average

-1.708B

Median

Sep 2022

Cash from Investing (TTM) Benchmarks